CMS will now post new performance information on their website, including quality-of-care deficiency findings, and will refine the process for gauging an AOs ability to assess compliance.
Some stakeholders say short-term plans will destabilize ACA market, but these plans are not expected to divert consumers already enrolled, HHS officials say
Final rule would also expand drug pricing competition to drive down costs and eliminate controversial questions regarding opioids from the hospital patient experience survey.